MX350719B - Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria. - Google Patents

Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria.

Info

Publication number
MX350719B
MX350719B MX2013008890A MX2013008890A MX350719B MX 350719 B MX350719 B MX 350719B MX 2013008890 A MX2013008890 A MX 2013008890A MX 2013008890 A MX2013008890 A MX 2013008890A MX 350719 B MX350719 B MX 350719B
Authority
MX
Mexico
Prior art keywords
treatment
inflammatory hyperpigmentation
bakuchiol
post inflammatory
disclosed
Prior art date
Application number
MX2013008890A
Other languages
English (en)
Spanish (es)
Other versions
MX2013008890A (es
Inventor
Jia Qi
Feng Hong Mei
Alfaro Brownell Lidia
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigen Inc filed Critical Unigen Inc
Priority claimed from PCT/US2012/023686 external-priority patent/WO2012106551A1/en
Publication of MX2013008890A publication Critical patent/MX2013008890A/es
Publication of MX350719B publication Critical patent/MX350719B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2013008890A 2011-02-02 2012-02-02 Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria. MX350719B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438890P 2011-02-02 2011-02-02
PCT/US2011/026594 WO2012105990A1 (en) 2011-02-02 2011-03-01 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
PCT/US2012/023686 WO2012106551A1 (en) 2011-02-02 2012-02-02 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Publications (2)

Publication Number Publication Date
MX2013008890A MX2013008890A (es) 2013-10-17
MX350719B true MX350719B (es) 2017-09-14

Family

ID=46603028

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008890A MX350719B (es) 2011-02-02 2012-02-02 Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria.

Country Status (8)

Country Link
KR (5) KR102642352B1 (pt)
CN (2) CN105147533B (pt)
AU (1) AU2012212153B9 (pt)
BR (1) BR112013019798A2 (pt)
CA (4) CA3128718A1 (pt)
HK (1) HK1215792A1 (pt)
MX (1) MX350719B (pt)
WO (1) WO2012105990A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471035B2 (en) 2014-10-20 2019-11-12 Sunny BioDiscovery Compositions and methods for using esters of meroterpenes and of other resveratrol analogues
CN105675741A (zh) * 2015-12-30 2016-06-15 成都九芝堂金鼎药业有限公司 一种测定生发丸中有效成分含量的方法
KR20190116858A (ko) 2018-04-05 2019-10-15 주식회사 엑소코바이오 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 염증후 과색소침착의 예방, 완화, 감소 내지는 제거 용도
CN111544317B (zh) * 2020-04-29 2022-01-14 珀莱雅化妆品股份有限公司 一种抗衰老组合物阳离子纳米脂质体及其制备方法与应用
CN114478196B (zh) * 2021-01-27 2023-11-10 江苏巴帝恩生物科技有限公司 一种从春榆根里提取补骨脂酚并纯化的方法及在化妆品中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617473B2 (ja) 1987-06-30 1997-06-04 キヤノン株式会社 情報入力装置
WO2006122160A2 (en) 2005-05-09 2006-11-16 Unigen Pharmaceuticals, Inc. Compositions of bakuchiol and methods of making the same
WO2008143761A1 (en) * 2007-05-14 2008-11-27 Sytheon Ltd. Sunscreen compositions and methods

Also Published As

Publication number Publication date
CA3128718A1 (en) 2012-08-09
CA2826262A1 (en) 2012-08-09
AU2012212153B9 (en) 2017-05-11
KR20200108120A (ko) 2020-09-16
AU2012212153A1 (en) 2013-08-29
CA3128711A1 (en) 2012-08-09
KR20210145864A (ko) 2021-12-02
CN105147533B (zh) 2018-07-31
BR112013019798A2 (pt) 2017-07-04
AU2012212153B2 (en) 2017-04-06
KR102525516B1 (ko) 2023-04-24
KR101954118B1 (ko) 2019-03-05
CN103458882B (zh) 2015-08-05
KR102333655B1 (ko) 2021-12-01
CN103458882A (zh) 2013-12-18
CA3128715A1 (en) 2012-08-09
KR102642352B1 (ko) 2024-02-28
KR20190025740A (ko) 2019-03-11
MX2013008890A (es) 2013-10-17
KR102156731B1 (ko) 2020-09-16
WO2012105990A1 (en) 2012-08-09
CA2826262C (en) 2021-10-26
HK1215792A1 (zh) 2016-09-15
CN105147533A (zh) 2015-12-16
KR20140008364A (ko) 2014-01-21
KR20230058727A (ko) 2023-05-03

Similar Documents

Publication Publication Date Title
WO2012106551A1 (en) Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
IN2015DN02573A (pt)
PH12014501561A1 (en) Therapeutically active compounds and their methods of use
EP2477985A4 (en) CANCER TREATMENT
IN2014DN09434A (pt)
GB201118656D0 (en) New compounds
JO3091B1 (ar) مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
MX349004B (es) Nuevos compuestos.
PH12018500071A1 (en) Plinabulin compositions
IN2015DN01119A (pt)
MY175800A (en) Combination treatment of cancer
IN2014DN06104A (pt)
PH12016500136A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
MX350719B (es) Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
PH12014500990A1 (en) Methods for treating gout flares
BR112016029012A2 (pt) método de tratamento de câncer de pulmão de células não pequenas e/ou câncer de pulmão de células pequenas usando compostos de tienotriazolodiazepina
MX2015001488A (es) Tratamiento de la inflamacion utilizando serelaxina.
MX354667B (es) Metodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas.
GB201022049D0 (en) Methods
WO2012006585A3 (en) Use of interleukin-15 to treat cardiovascular diseases
WO2012112862A3 (en) Treating mycobacterial infection with cu+/++ boosting therapeutics
MD20140001A2 (ro) Modulatori alosterici pozitivi ai receptorului nicotinic al acetilcolinei
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica

Legal Events

Date Code Title Description
FG Grant or registration